Viridian Data Analytics
The Market Intelligence on Cannabis/CBD/Psychedelic Capital Raise and M&A Transactions Used by Companies, Investors, Acquirers and Advisors to Make Informed Capital Allocation and M&A Decisions.
Cannabis/CBD/Psychedelic Deals
Trailing Twelve Months
$0.71B
Equity Capital Raised
90
# Equity Transactions
$1.11B
Debt Capital Raised
60
# Debt Transactions
$1.65B
M&A Transaction Value
103
# M&A Transactions
Testimonials
“Viridian has collected and aggregated the world’s largest database of cannabis deals.” – Benzinga
“The Viridian team was by our side throughout the capital raise process and helped us source and negotiate the optimal debt financing. The market intelligence they gave us using information from the Viridian Cannabis Deal Tracker was instrumental in negotiating the best transaction.” – Ryan Jenneman, THC Design CEO
“We especially want to thank the team at Viridian Capital for their sage counsel on valuation and deal structures throughout the M&A process that helped guide us to a successful close.” — Jordan Weiss, CEO, Green Coast Hydroponics
Viridian Cannabis Deal Tracker
Launched in January 2015, and having analyzed more than $60B in deals, the Viridian Cannabis Deal Tracker is a proprietary data service that monitors and analyzes capital raise and M&A activity in the legal Cannabis/CBD/Psychedelics industries. Each week the Deal Tracker provides proprietary data and market intelligence on transactions, including:
- Deals by Industry Sector (to track the flow of capital and M&A deals by one of 12 Sectors - from cultivation to brands to software)
- Deal Structure (equity/debt for capital raises, cash/stock/earnout for M&A)
- Principals to the Transaction (issuer/investor/lender/acquirer)
- Key Deal Terms (deal size, valuation, pricing, warrants, cost of capital)
- Deals by Location of Issuer/Buyer/Seller (to track the flow of capital and M&A deals by state and country)
- Credit Analysis (leverage and liquidity ratios)
DETAILED DESCRIPTION OF DATA SERVICES
Equity Deals
Provides weekly data and insight into Cannabis/CBD/Psychedelic industries equity issuances
Debt Deals
Provides weekly data and insight into Cannabis/CBD/Psychedelic industries debt issuances
M&A Deals
Provides weekly data and insight into Cannabis/CBD/Psychedelic industries M&A deals.
Valuation Tracker
Provides valuation analysis for over 370 public Cannabis/CBD/Psychedelic companies.
Credit Tracker
Provides credit/liquidity analysis and rankings for over 370 public cannabis/CBD companies.
Industry Sector Tracker
Analyzes transactions by industry sector in order to track the flow of capital and M&A across 12 industry sectors – from cultivation to brands to software.
Regional Tracker
Analyzes deals by location of issuer/seller in order to track the flow of capital and M&A deals by state and country.
Chart of the Week
Provides insight on the most influential trends from the past week in the Cannabis/CBD/Psychedelic industries.
LATin america deal tracker
The Latin America Deal Tracker is a monthly report that includes all equity, debt, and M&A transactions that occurred in the region.
European
Deal Tracker
The European America Deal Tracker is a monthly report that includes all equity, debt, and M&A transactions that occurred in the region.
YTD Charts for Capital Raises
Consists of an overview of capital raise activity in the Cannabis/CBD/Psychedelic industries from the current year.
YTD Charts
for M&A
Consists of an overview of the M&A activity in the Cannabis/CBD/Psychedelic industries from the current year.
Viridian Capital Advisors Offers unique propriety data services including:
- Equity Deals
- Debt Deals
- M&A Deals
- Valuation Tracker
- Credit Tracker
- Sector Tracker
- Regional Tracker
- Special Reports
- Chart of the Week
- YTD Charts for Capital Raises
- YTD Charts for M&A
Examples of our data, analytics, and market intelligence
Equity Deal Tracker
The Equity Deal Tracker includes a weekly analysis of equity issuance. Data includes issuer specific information, deal size, pricing, share information, deal implied valuation information, and warrant information.
M&A Deal Tracker
The M&A Deal Tracker includes a weekly analysis of mergers & acquisitions in the cannabis industry. Weekly data on deals includes the acquiror and target information, deal size, type of deal, structure, and valuation information.
Credit Tracker
When it comes to credit ratings for Cannabis/CBD/Psychedelic companies, many investors, acquirers, and lenders have been left in the dark with a lack of information. With Viridian’s data and market intelligence, that is no longer the case. The Viridian Cannabis Credit Tracker is the first of its kind, providing users with a proprietary credit ranking system for companies based on a company’s liquidity, leverage, profitability, and size.
Viridian Cannabis Deal tracker for the week ended 3/8/24
Viridian Insights of the week
- Rumors of potential dissent within the DEA were enough to send the market into a headlong retreat, with the MSOS down 8.6% for last week and an additional 8.4% for the first two days of this week. It clearly shows how single-minded the market has become regarding rescheduling. While we cannot handicap what is happening behind closed doors at the DEA, we have pointed out that several significant MSOs like GTI, Verano, and Trulieve are not dependent on a kick save from 280e relief. That may not save the stocks in the event of an adverse rescheduling announcement (which we continue to view as unlikely) since the entire market would likely trade off sharply; it at least means that these companies are not facing a fiscal cliff or a need to dilute shareholders to pay off debt.
- After several unusually strong trading weeks in early February, primarily created by false rumors of imminent rescheduling announcements and the portfolio rebalancing by the MJUS ETF, trading volume has been off sharply in the last three weeks. More telling is the increases in the Days to Trade Market Cap (DTTMC) series, which eponymously depicts the number of days it would take to trade the market cap of a stock or group of stocks. Its most recent reading of 484 days is above the downward trend line shown on the graph. The reality is that very little new institutional capital has come into the cannabis market. The investors are still the same, and many are not committing additional funds to the industry until some of the regulatory smoke clears. Will rescheduling change this? Perhaps, but not directly. Still, at the margin, the cash-flow-enhancing impacts of Schedule 3 will make cannabis more investible and attract more capital.
- Cannabis equities (as measured by the MSOS ETF) were down 8.68% for the week.
- EV/NTM EBITDA Multiples fell sharply this week and are now 25.2% below the levels after the 5th SAFE Act passage in the House in February 2022. Still, the rescheduling news is more significant as it dramatically impacts cash flows. If valuations multiples rose to where they were after the announcement of the Schumer-Booker bill, the incremental gains would equal 102.7%. We view a DEA announcement ratifying the HHS recommendation to be much more significant than introducing the Schumer-Booker bill, which most observers viewed as DOA and had no immediate impact on operator cash flows. Accordingly, we believe there is considerably more runway for price increases, perhaps reaching the 5/7/21 multiples of 18.35x, producing 136.5% returns from current levels.
Equity Deals For this week
This week there were two equity transactions, totaling to $8.33M. This was highlighted by PSYLO PTY (Private) closing a Seed Funding round for $5M.
Debt Deals For this week
This week there was one debt transaction, totaling $375.00M. This was highlighted by Verano Holdings (VRNO: CSE), the fourth largest U.S. MSO by market cap, completed a $350M refinancing of its existing credit line.
M&A Deals for this Week
This week there were three transactions, totaling $27.36M This was highlighted by High Tide Inc. (HITI: Nasdaq) confirmed that it had closed its previously announced acquisition of Jimmy’s Cannabis Shop BC. The purchase includes two retail locations in Prince George and Cranbrook, BC.
Viridian Valuation Tracker
This week’s valuation tracker focuses on the twenty-seven U.S. Cultivation & Retail companies in the Viridian Value Tracker database with market caps under $100M.
Viridian Credit Tracker
This week’s credit tracker focuses on the sixteen U.S. Cultivation & Retail sector companies in the Viridian Value Tracker database with market caps over $100M.
Viridian Sector Deal Tracker
This week’s Viridian Industry Sector Tracker highlights Psychedelics, an industry that has recently seen a rise in the total number of capital raises YTD.
Viridian Regional Deal Tracker
Illinois increased its hold as the third largest state for capital raises through the Verano $350M refinancing debt deal which is the largest debt YTD.
Latin america deal tracker
The Latin America Deal Tracker is a monthly report that includes all equity, debt, and M&A transactions that occurred in the region. The LATAM deal tracker also gives a transactions review and year over year trends.
European Deal Tracker
The Europe America Deal Tracker is a monthly report that includes all equity, debt, and M&A transactions that occurred in the region. The European Deal Tracker also gives a transactions review and year over year trends.
YTD Charts for Capital Raises
The YTD charts provide data and insights into the public vs. private capital raises for the current year, total number and dollar amount of capital raises each week, and capital raises by sector.
YTD Charts for M&A
The YTD charts provide data and insights into the public vs. private mergers & acquisitions for the current year, total number and transaction value of M&A deals by week, and M&A deals by sector.
Chart of the Week
The Viridian Capital Chart of the Week highlights key investment, valuation and M&A trends taken from that week’s Deal Tracker that we believe are impactful for investors, companies and acquirers.